Fibrosis is the body process in which excess fibrous connective tissue is formatted in the organ or tissue in repetitive way. Fibrosis may be resulted by specific injuries or diseases. Kidney fibrosis is the common pathway for the chronic kidney disease (CKD) or end-stage kidney diseases (ESRD). Kidney fibrosis is caused by the excessive formation of the extracellular matrix, which is the common phenomenon caused by each type of CKD. Currently, kidney fibrosis market is facing lucrative growth owing to rising incidences of CKDs and renal fibrosis. Increasing patients’ base may promote the future growth of this market.
It is observed that any type of disease, leading to chronic kidney disorder (CKD), may further progress in renal fibrosis. Obesity accelerate the incidence of kidney fibrosis, additionally, habits such as smoking may promote the growth of kidney fibrosis. Geographically, North America would be the lucrative market owing to the wide patient base suffering from CKDs. As per the Centers for Disease Control and Prevention (CDC), ~20 million people are suffering from various types of CKDs of different severity level in 2014. CDC also elaborates that, ~113,136 people in the United States initiated their treatments for end-stage kidney diseases (ESRD) in 2011. The market will be driven by rising health awareness and health concerns among various population groups. However, stringent regulatory approvals related with kidney fibrosis therapeutics may hinder the market growth. Recent technological breakthrough for example, point-of-care drug delivery systems would be the growth opportunities in this market.
The Kidney fibrosis market is segmented based on therapeutics, location of testing, and geography. Based on the type of treatment, the market is further segmented into Angiotensin Converting Enzyme (ACE) inhibitors, Angiotensin II receptor blockers (ARBs), Pirfenidone, Renin Inhibitors and Vasopeptidase Inhibitors. Based on the location of testing, the market is segmented into hospital, clinic, and home treatments. Currently, hospitals perform a majority of tests and would continue to hold a larger market share, both in terms of volume and revenue of the treatments. Geographically, the global Kidney Fibrosis Treatment Market is segmented into North America, Europe, Asia-Pacific, and LAMEA.
Some of the key players working in the kidney fibrosis treatment market include Merck & Co., F. Hoffman-La Roche Ltd., Pfizer Inc., Galectin Therapeutics, La Jolla Pharmaceutical Company, InterMune Inc., ProMetic Life-Sciences Inc., Genzyme Corporation, BioLine Rx Ltd among others.
KEY MARKET SEGMENTS
The market is segmented based on the type of treatments, location of testing, and by the geography.
KIDNEY FIBROSIS TREATMENT MARKET BY THERAPEUTICS
KIDNEY FIBROSIS TREATMENT MARKET BY LOCATION OF THERAPEUTICS
KIDNEY FIBROSIS TREATMENT MARKET BY GEOGRAPHY
SIMILAR MARKET STUDIES
Summary This report presents data on the Self-Tan consumption trends in Austria. It analyzes Self-Tan consumption volumes and values at market and category level. It examines the components of change in the market for the historic (2008-2013) and forecast (2014-2018) years by volumes and values, as well as the manner in which ...
March 2015 | $200 | View Details >>
This report presents data on the Male Toiletries consumption trends in Mexico. It analyzes Male Toiletries consumption volumes and values at market and category level. It examines the components of change in the market via study of 2006, 2011 and 2016 volumes and values, as well as the manner in which changes in consumer behavior have affected total volumes, values and the type of products chosen.
November 2012 | $200 | View Details >>
This report presents data on the Denture Care consumption trends in Israel. It analyzes Denture Care consumption volumes and values at market and category level. It examines the components of change in the market for the historic (2007-2012) and forecast (2013-2017) years by volumes and values, as well as the manner in which changes in consumer behavior have affected total volumes, values and the type of products chosen.
December 2013 | $200 | View Details >>
The Global Human Coagulation Factor VIII Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Human Coagulation Factor VIII industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Human Coagulation Factor VIII market ...
September 2015 | $2800 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research